In vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens

BMC Microbiology

Volumn 17, Issue 1, 2017, Pages

  Golić, Nataša ^a   Veljović, Katarina ^a   Popović, Nikola ^a,b   Djokić, Jelena ^a   Strahinić, Ivana ^a   Mrvaljević, Igor ^b   Terzić Vidojević, Amarela ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Centre for Development and Production   (Serbia)

Author keywords

Clostridium sp.; GALT; Goats; Probiotic; TGF

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE; INTERLEUKIN-1BETA (163-171); PEPTIDE FRAGMENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CACO-2 CELL LINE; CAPRINE MODEL; CELL PROTECTION; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM PERFRINGENS INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG MECHANISM; FEMALE; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE LYMPHATIC TISSUE; LACTOBACILLUS FERMENTUM; LACTOBACILLUS HELVETICUS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTOCLOSTRIDIUM DIFFICILE; RAT; STREPTOCOCCUS THERMOPHILUS; UPREGULATION; ANIMAL; ANTIBIOSIS; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; CLOSTRIDIUM INFECTION; DISEASE MODEL; DRUG EFFECTS; EPITHELIUM CELL; GOAT; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; VETERINARY;

ANIMALS; ANTIBIOSIS; CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GOATS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTESTINES; LACTOBACILLUS FERMENTUM; LACTOBACILLUS HELVETICUS; MICROBIAL SENSITIVITY TESTS; PEPTIDE FRAGMENTS; PROBIOTICS; STREPTOCOCCUS THERMOPHILUS;

EID: 85018741414     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-017-1015-5     Document Type: Article

References (36)

1. Janezic S, Zidaric V, Pardon B, Indra A, Kokotovic B, Blanco JL, Seyboldt C, Diaz CR, Poxton IR, Perreten V, Drigo I, Jiraskova A, Ocepek M, Weese JS, Songer JG, Wilcox MH, Rupnik M. International Clostridium difficile animal strain collection and large diversity of animal associated strains. BMC Microbiol. 2014;14:173.
2. Uzal FA, Freedman JC, Shrestha A, Theoret JR, Garcia J, Awad MM, Adams V, Moore RJ, Rood JI, McClane BA. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 2014;9:361-77.
3. Seekatz AM, Young VB. Clostridium difficile and the microbiota. J Clin Invest. 2014;124:4182-9.
4. Kujawa-Szewieczek A, Adamczak M, Kwiecien K, Dudzicz S, Gazda M, Wiecek A. The effect of Lactobacillus plantarum 299v on the incidence of Clostridium difficile infection in high risk patients treated with antibiotics. Nutrients. 2015;7:10179-88.
5. Silva RO, Lobato FC. Clostridium perfringens: A review of enteric diseases in dogs, cats and wild animals. Anaerobe. 2015;33:14-7.
6. McClane BA, Robertson SL, Li J. Clostridium perfringens. In: Doyle MP, Buchanan RL, editors. Food microbiology: fundamentals and frontiers. 4th edn. Washington, DC: ASM Press; 2013. p. 465-89.
7. Valdes-Varela L, Alonso-Guervos M, Garcia-Suarez O, Gueimonde M, Ruas-Madiedo P. Screening of bifidobacteria and lactobacilli able to antagonize the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer. Front Microbiol. 2016;7:577.
8. Caly DL, D’Inca R, Auclair E, Drider D. Alternatives to antibiotics to prevent necrotic enteritis in broiler chickens: A microbiologist’s perspective. Front Microbiol. 2015;6:1336.
9. Joint Food and Agriculture Organization/World Health Organization. FAO-WHO. Probiotics in food: health and nutritional properties and guidelines for evaluation, FAO Food and Nutritional Paper No. 85 (ISBN 92-5-105513-105510). Rome: Food and Agriculture Organization of the United Nations, World Health Organization; 2016.
10. Strahinic I, Lozo J, Terzic-Vidojevic A, Fira D, Kojic M, Golic N, Begovic J, Topisirovic L. Technological and probiotic potential of BGRA43 a natural isolate of Lactobacillus helveticus. Front Microbiol. 2013;4:2.
11. Tompa G, Laine A, Pihlanto A, Korhonen H, Rogelj I, Marnila P. Chemiluminescence of non-differentiated THP-1 promonocytes: developing an assay for screening anti-inflammatory milk proteins and peptides. Luminescence. 2011;26:251-8.
12. Lukic J, Strahinic I, Milenkovic M, Golic N, Kojic M, Topisirovic L, Begovic J. Interaction of Lactobacillus fermentum BGHI14 with rat colonic mucosa: implications for colitis induction. Appl Environ Microbiol. 2013;79:5735-44.
13. Adams BW, Mead GC. Comparison of media and methods for counting Clostridium perfringens in poultry meat and further-processed products. J Hyg. 1980;84:151-8.
14. European Food Safety Authority (EFSA). Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA panel on additives and products or substances used in animal feed (FEEDAP). EFSA Journal. 2012;10:2740.
15. Banina A, Vukasinovic M, Brankovic S, Fira D, Kojic M, Topisirovic L. Characterization of natural isolate Lactobacillus acidophilus BGRA43 useful for acidophilus milk production. J Appl Microbiol. 1998;84:593-9.
16. Nikolic M, Lopez P, Strahinic I, Suarez A, Kojic M, Fernandez-Garcia M, Topisirovic L, Golic N, Ruas-Madiedo P. Characterisation of the exopolysaccharide (EPS)-producing Lactobacillus paraplantarum BGCG11 and its non-EPS producing derivative strains as potential probiotics. Int J Food Microbiol. 2012;158:155-62.
17. Hidalgo-Cantabrana C, Nikolic M, López P, Suárez A, Miljkovic M, Kojic M, Margolles A, Golic N, Ruas-Madiedo P. Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue. Anaerobe. 2014;26:24-30.
18. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol. 2007;23:679-92.
19. Ollech JE, Shen NT, Crawford CV, Ringel Y. Use of probiotics in prevention and treatment of patients with Clostridium difficile infection. Best Pract Res Clin Gastroenterol. 2016;30:111-8.
20. Hickson M, D’Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80.
21. Hickson M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol. 2011;4:185-97.
22. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol. 2004;7:59-62.
23. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31:1012-7.
24. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14:141-53.
25. Zeuthen LH, Fink LN, Frokiaer H. Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta. Immunology. 2008;123:197-208.
26. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, Nespoli A, Viale G, Allavena P, Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol. 2005;6:507-14.
27. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007;204:1757-64.
28. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662-5.
29. Walia B, Wang L, Merlin D, Sitaraman SV. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2. FASEB J. 2003;17:2130-2.
30. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374:1-20.
31. Reinisch W, Gasche C, Tillinger W, Wyatt J, Lichtenberger C, Willheim M, Dejaco C, Waldhör T, Bakos S, Vogelsang H, Gangl A, Lochs H. Clinical relevance of serum interleukin-6 in Crohn’s disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroentrol. 1999;94:2156-64.
32. Huang IF, Lin IC, Liu PF, Cheng MF, Liu YC, Hsieh YD, Chen JJ, Chen CL, Chang HW, Shu CW. Lactobacillus acidophilus attenuates Salmonella-induced intestinal inflammation via TGF-beta signaling. BMC Microbiol. 2015;15:203.
33. Barletta B, Rossi G, Schiavi E, Butteroni C, Corinti S, Boirivant M, Di Felice G. Probiotic VSL#3-induced TGF-beta ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa. Mol Nutr Food Res. 2013;57:2233-44.
34. Diegelmann J, Olszak T, Goke B, Blumberg RS, Brand S. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. J Biol Chem. 2012;287:286-98.
35. Leslie JL, Huang S, Opp JS, Nagy MS, Kobayashi M, Young VB, Spence JR. Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function. Infect Immun. 2015;83:138-45.
36. Schoster A, Staempfli HR, Abrahams M, Jalali M, Weese JS, Guardabassi L. Effect of a probiotic on prevention of diarrhea and Clostridium difficile and Clostridium perfringens shedding in foals. J Vet Intern Med. 2015;29:925-31.